Evaluation of injectable silica-embedded nanohydroxyapatite bone substitute in a rat tibia defect model

Bone regeneration remains a critical challenge in orthopedic surgery. Current treatments for bone defects include autografts and allografts, but these options have limitations such as donor site morbidity and limited availability. Synthetic bone substitutes have been developed to overcome these issues. However, many synthetic materials lack the osteoinductive properties needed for effective bone regeneration. Recent studies have explored injectable materials that can be delivered minimally invasively. This gap motivated researchers to develop a full synthetic injectable bone substitute with improved osteoinductive and bioresorbable properties. Prior research has shown that hydroxyapatite-based materials can support bone regeneration, but their injectability and degradation rates remain unresolved. No prior work had resolved how to embed nanocrystallites in a silica matrix to enhance both injectability and osteoinductivity. This paper addresses that uncertainty by introducing a novel injectable composite material.

The primary aim of this study was to evaluate a newly developed injectable bone substitute composed of nanohydroxyapatite embedded in amorphous silica gel. The researchers sought to determine whether this material could promote bone regeneration in a rat tibia defect model. The specific problem addressed was the need for a synthetic injectable material that can degrade while supporting new bone formation. The motivation for this work stems from the limitations of current bone grafting materials in clinical settings. The study aimed to characterize the material's structure and assess its osteoinductive and bioresorbable properties in vivo. By implanting the material in a tibial defect and monitoring the healing process, the researchers hoped to establish the material's potential for clinical applications such as kyphoplasty. The study also aimed to determine whether the material could be fully replaced by newly formed bone over time.

The injectable bone substitute was manufactured using spray drying to produce donut-like microparticles composed of nanocrystallites of synthetic hydroxyapatite embedded in amorphous silica gel. The material was implanted into a proximal tibial diaphyseal defect in 52 rats. Grafts were harvested at multiple time points for histological and radiographic analysis. The study design involved a longitudinal assessment of the healing process in the same cohort of animals. Histological sections were prepared to evaluate new bone formation and the degradation of the biomaterial. Radiographic imaging was used to monitor the structural changes in the defect over time. The researchers assessed the presence of hematomas, cortical wounds, and the composition of the wound region at different stages of healing. The study also evaluated the extent of new bone formation in the medullary space and the replacement of the graft material with bone marrow. The analysis focused on the timeline of bone regeneration and the complete healing of the cortical defect.

Newly formed bone originating from the endosteum was observed within six days of implantation. Hematomas in the medullary space and cortical wounds were no longer present by day 12. The wound region was completely replaced by a composite of newly formed cancellous bone, extracellular matrix, and the injectable bone substitute. By day 63, the cortical defect was fully healed by bone. The newly formed bone in the medullary space almost disappeared and was replaced with bone marrow. The material demonstrated osteoinductive properties, as evidenced by the rapid formation of new bone. The biomaterial also showed bioresorbable characteristics, as it was gradually replaced by bone tissue. The degradation of the injectable material coincided with the progression of bone regeneration. These findings suggest that the material supports both structural healing and functional recovery of the bone defect.

The injectable bone substitute demonstrated a unique structure with osteoinductive and bioresorbable properties. The material induced rapid bone regeneration in the rat tibia defect model. The findings suggest that the synthetic injectable material can be fully replaced by newly formed bone over time. The material's ability to support endosteal bone formation and degrade in sync with healing is a key finding. The replacement of the graft with bone marrow in the medullary space indicates functional recovery. The complete healing of the cortical defect by day 63 supports the material's efficacy. These results align with the authors' claim that the material has promising potential for clinical applications such as kyphoplasty. The study's findings are specific to the rat model and do not generalize beyond the scope of this investigation.